![](/img/cover-not-exists.png)
SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology
J. Glennon, A.C. McCreary, E. Ronken, R. Siarey, M.B. Hesselink, R. Feenstra, B. Van Vliet, S.K. Long, C.G. KruseVolume:
12
Year:
2002
Language:
english
DOI:
10.1016/s0924-977x(02)80381-9
File:
PDF, 125 KB
english, 2002